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1. Introduction 
Access to increasingly sophisticated medical care over the last century has improved the 
prevention and treatment of many diseases that had previously been fatal, including 
pneumonia, tuberculosis, acute and chronic renal failure, some cancers, and myocardial 
infarction. Despite these important curative advances, insufficient emphasis was initially 
placed on the importance of relieving symptoms and providing continuing support to 
patients with limited prognosis of survival. A response to this deficiency was the 
emergence, in the sixties, of Hospice and Palliative Care movements, which sought to 
improve the quality of care of terminally ill patients and their families (Saunders, 2004). 
The primary goal of palliative care therapy is the optimal relief of multiple physical and 
psychological symptoms, with careful consideration of the spiritual and social needs of the 
patients and their families (Billings, 1998; WHO, 2004). To achieve optimal symptomatic relief, 
it is important not only to assemble a multidisciplinary team that is able to consider all aspects 
of the patient's situation, but also to ensure that they are able to provide coordinated and 
interdisciplinary therapeutic assistance to the patient. To achieve this, it is necessary that the 
members of the team fully understand the relationship between the myriad physical, 
psychological, spiritual, and social aspects of the individual and his environment. 
It is sometimes assumed in clinical practice that symptoms of depression or anxiety can 
influence the intensity and persistence of certain physical symptoms (Vignaroli et al., 2006). 
Another common assumption is that physical symptoms can trigger depression or anxiety. 
However, these assumptions are not firmly supported by scientific data, as a number of 
international studies that have attempted to explore this relationship have reported 
contradictory results (Lloyd-Williams et al., 2004a; Chen & Chang, 2004; Teunissen et al., 
2007a). There are no national studies to explain the potential link between emotional 
suffering and the intensity and frequency of physical symptoms other than pain.  
Depressive and anxiety symptoms can reflect the existence of a psychiatric pathology. 
Anxiety and mood disorders occur frequently in patients with advanced chronic disease, 
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(Teunissen et al., 2007b; Lloyd-Williams et al., 2003; Wilson et al., 2007; Durkin et al., 2003; 
Meyer et al., 2003; Noorani & Montagnini, 2007) with the observed prevalence fluctuating 
between 17 and 46% for the former disorder, (Teunissen et al, 2007a) and between 5% and 
26% in the latter (Hotopf et al., 2002). Regardless of the frequency of these disorders and 
their relevance to diagnosis and treatment, they are frequently under diagnosed (Vignaroli 
et al., 2006; Durkin et al., 2003; Palma et al., 2008; Breitbart, 1995). This low level of detection 
may be related to the as-yet-incomplete incorporation of mental health professionals into 
medical teams, as well as to insufficient medical training in the detection, assessment, and 
treatment of psychiatric disorders. 
The Hospital Anxiety and Depression Scale (HADS) is one of the more commonly used tools 
to screen for anxiety and depression in hospitalized patients. Although this scale has proven 
to be a reliable and valid instrument for assessing anxiety and depression in patients with 
physical illness (Bjelland et al., 2002), its length makes it difficult to apply in terminally ill 
patients, who require continuing assessment of multiple additional symptoms. The 
Edmonton Symptom Assessment System (Bruera et al., 1991; Dudgeon et al., 1999; Chang et 
al., 2000) (ESAS) is a concise, valid, and internationally used tool in palliative care Chang et 
al., 2000), which uses self-report scales to evaluate objectively the multiple symptoms 
observed in this group of patients. A particular advantage of the ESAS is that it is a simple 
and quickly administered tool that requires very little effort and concentration from the 
patient. Nevertheless, the anxiety and depressive components of this scale in Spanish have 
not been validated for the detection of depression and anxiety.  
The main goal of this study is to determine if anxiety or depressive symptoms shows a 
positive correlation with the intensity and frequency of physical symptoms in hospitalized 
patients with advanced chronic diseases. Additionally it seeks to compare the ESAS and 
HADS as screening tools for anxiety and depressive symptoms in this population. 
2. Material and methods  
This study was conducted in the internal medicine wards of the Clinical Hospital of the 
Pontificia Universidad Católica de Chile during seven months, and Sotero del Río Hospital 
during four months. It was approved by the ethics committee of both hospitals.   
During the study period, 2280 patients were hospitalized in the internal medicine wards of 
both hospitals. Of these, 150 patients met the initial criteria for inclusion by being diagnosed 
with chronic disease at an advanced stage, including: (1) advanced cancer, including 
haematological neoplasia or solid metastasis not responding to medical treatment; (2) 
pulmonary obstructive lung disease with a functional class NYHA III-IV and/or requiring 
additional oxygen on a permanent basis; (3) chronic liver failure categorized as Child C in 
its basal condition; or (4) heart failure with functional class NYHA III/IV in its basal 
condition. The main exclusion criteria was the presence of delirium, assessed with the 
Confusion Assessment Method. Of this group, 124 did not present with delirium and were 
admitted to our study.  
On each service, the patients admitted each day were evaluated according to these criteria 
by systematic review of their medical charts, lab tests and clinical status. Patients with no 
evidence of delirium were asked to sign an informed consent form. Social, demographic and 
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clinical data were registered: age, sex, health insurance, educational level, date of diagnosis 
of the underlying disease, cause of hospitalization, co-morbidities and basal Karnofsky 
score. 
2.1 Patient assessment 
We used ESAS scale to evaluate the presence and intensity of physical symptoms reported 
by each patient. Symptoms of anxiety and depression was evaluated using HADS and ESAS 
scales, both of which have been validated and translated into Spanish (Vignaroli et al., 2006; 
Bjelland et al., 2002; Bruera et al., 1991; Dudgeon et al., 1999; Chang et al., 2000; Herrero et 
al., 2003; Walker et al., 2007; Quintana et al., 2003; Tejero et al., 1986). 
The ESAS scale evaluates the symptoms that occur most frequently in advanced chronic 
disease, including: pain, fatigue, nausea, depression, anxiety, somnolence, dyspnea, 
insomnia, and reduction of one's global sense of wellness. Each symptom is assessed using a 
self-reporting scale where 0 mean absence of symptom and 10 indicates the presence of the 
symptom at its maximum possible intensity. Symptoms of anxiety and depression were 
considered to be present when the intensity of the symptom was 1 or more. The HADS scale 
consists of two 7-item subscales, one for depression and one for anxiety. Each item is rated 
on a 4-point scale, scored from 0 to 3. In 1983, the authors of the scale, Zigmond and Snaith, 
proposed that a score greater than 11 indicates a clinical problem and a score from 8 to 10 
indicates that the status of the symptom is uncertain, while a score of 7 or less indicates the 
absence of the symptom(25). 
All researchers participating in the study had been previously trained in the proper 
application of the scales used. A separate investigator was assigned to audit the correct 
registration of findings in each of the cases included in the protocol. In order to avoid 
registration errors, two additional researchers coded and tabulated the information in an 
electronic database.   
2.2 Statistical analysis 
The numerical variables of the study were presented as mean with standard deviation, or, 
in a small number of cases, as the median. Categorical variables were presented as 
number of cases and percent. We used the nonparametric Mann-Whitney test to compare 
numerical variables between groups, and the chi-square or exact Fisher tests to compare 
percentages.   
To determine the validity of the ESAS as a diagnostic test, using the HADS as the gold 
standard, we analyzed both sensitivity and specificity. The grade of agreement between 
ESAS and HADS was determined by the Kappa test. P values not greater than 0.05 were 
considered significant. All statistical analyses were carried out using SPSS 16.0 software. 
3. Results  
To evaluate the relationship between physical symptoms and symptoms of anxiety or 
depression, profiles of depressed and non-depressed patients and anxious and non-anxious 
patients were compared in terms of the number and intensity of symptoms. 
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Of 124 patients who met the inclusion criteria of the study, 5 were too emotionally disturbed 
to answer the HADS, and were excluded to receive psychological assistance. Of the 
remaining 119 patients, most were female (58%), with an average age of 66.9 years (range 
35–95), and a mean basal Karnofsky score of 70 (range 30–100). Regarding their admission 
diagnosis 55 patients had cancer and 61 were diagnosed with non-oncological diseases.  
 
Variables N % Median (range) 
Total participants 119 - - 
Age (years) - - 66.9  (35-95) 
Sex (M/F) (n,%)  49 / 70 48 / 52 - 
Married or communal                               72 60.7 - 
Single     16 13.4 - 
Separated or widow                                   31 25.9 - 
With Religion                                          102 85.7 - 
Working      29 24.4 - 
Stopped Work 28 23.5 - 
Retired 56 47.1 - 
Karnofsky - - 69.8 (30-100) 
With Cancer 55 47.4 - 
1. Digestive 14 25.5 - 
2. Blood 11 20.0 - 
3. Lung 13 10.9 - 
4. Breast/Gynological 02 3.6 - 
5. Other 15 27.3 - 
Wihtout Cancer 61 52.6 - 
1. Chronic Liver Failure Child C 17 27.9 - 
2. Chronic Cardiac Failure CF IV 24 39.3 - 
3. Pulmonary Obstructive Lung Disease 20 32.8 - 
Table 1. Clinical characteristics and social demographics of the study cohort 
We found a high prevalence of physical symptoms, fatigue being the most common (78.9%), 
followed by insomnia (78.7%), anorexia (76.2%), and somnolence (71.3%). At least 60% of 
patients reported their symptoms were of moderate to severe intensity (between 4 and 10 
points on the self-report scale).  
 
Symptoms Frequency
(%)
Mild
(%)
Moderate
(%)
Severe 
(%) 
Pain 61.8 22.8 26.8 12.2 
Fatigue 78.9 21.1 42.3 15.4 
Nausea 17.1 8.9 5.7 2.4 
Drowsiness 71.3 23.0 36.1 12.3 
Dyspnea 60.7 18.0 31.1 11.5 
Anorexia 76.2 18.9 30.3 27.0 
Depression 68.3 26.8 24.4 17.1 
Anxiety  71.3 23.8 34.4 13.1 
The symptoms were catalogued as mild-moderate-severe in accordance with ESAS scoring: Mild 1-3 / Moderate: 
4-7 / Severe: 8-10. 
Table 2. Frequency and intensity of symptoms 
www.intechopen.com
Are Anxiety and Depressive Symptoms Related to Physical Symptoms? 
A Prospective Study of Patients with Advanced Chronic Disease 
 
33 
According to HADS scoring, 13.6% of the patients presented with depression and 32.5% 
with anxiety. Using a cutoff score of 2, for ESAS, 67.5% of patients experienced anxiety and 
60.2% reported depressed mood.  
There was no significant difference in age, religious or marital status between patients with 
significant psychological distress, in the form of depression or anxiety according to HADS, 
and those who exhibited no psychological distress (Table III). However, significant 
statistical differences were found in gender, employment status and Karnofsky index. We 
observed that patients with psychological distress tended to be female, unemployed (87.2% 
of the subjects with psychological distress were not working), and having a lower basal 
Karnofsky index of 65, compared to 75 observed in the second group with no psychological 
distress (p = 0.027). 
 
Significant Psychological Distress*
 Present Absent  
 N (%) Median N (%) Median P 
Age - - 63.23 - - 66.94 .154 
Men 10 25 - 39 49.4 - .014 
Women 30 75 - 40 50.6 -  
With religion 36 92.3 - 66 88 - .477 
Without religion 3 7.7 - 9 12 -  
Single 3 7.9 - 12 16.2 - .365 
With a partner 23 60.5 - 45 60.8 -  
Separate or Widow 12 31.6 - 17 23 -  
Working 5 12.8 - 24 32.4 - .006 
Not working** 34 87.2 - 50 67.6 -  
Karnofsky - - 65.43 - - 74.93 .027 
* Presence of depression or anxiety matching HADS store.  
** Unemployed, not working, retire or pension  
Table 3. Analysis with respect to socio-demographic characteristics. for medical reason. 
3.1 Comparison of assessment tools for depression and anxiety  
Using HADS as a gold standard, ESAS was tested as a screening tool to detect depression 
and anxiety (Table IV). Using a cutoff score of 2 or more, we obtained a sensitivity of  87,5% 
for depression and 86.8% for anxiety and negative predictive values of 95.7% for depression 
and 86.8% for anxiety. These parameters dramatically decreased when a cutoff score of 5 
was used, obtaining sensitivity of 68% for depression and 63% for anxiety. 
 
 ESAS Depression ESAS Anxiety 
Cutoff Point 2 (%) 5 (%) 2 (%) 5 (%) 
Sensitivity 87.5 68.8 86.8 63.2 
Specificity 44.1 71.6 41.8 74.7 
Predictive value (+)     19.7 27.5 41.8 54.5 
Predictive value (-) 95.7 93.6 86.8 80.8 
Kappa      .129 .247 .224 .364 
P .016 .002 .002 .000 
Table 4. Sensitivity, specificity and predictive values of the ESAS as a diagnostic test using 
the HADS as the gold standard 
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3.2 Analysis based on physical symptom profiles 
Patients with anxiety had higher incidence of physical symptoms and greater severity of 
several symptoms compared with controls. As shown in Table V, the presence of anxiety 
was associated with a greater incidence of pain (p = .006), insomnia (p = .002), fatigue  
(p = .380), and nausea (p = .009). Likewise, as shown in Table VI, the presence of anxiety was 
associated with greater severity of pain (p= .001), fatigue (p= .003), anorexia (p= .022), 
insomnia (p= .001) and nausea (p= .009). Patients with anxiety also reported a greater loss of 
the sensation of global well-being (p= .004). 
Patients with depression also had a higher incidence of physical symptoms and greater 
severity of several symptoms relative to healthy controls. As shown in Table V, depressed 
patients had a higher frequency of anorexia (p = .014), fatigue (p = .021), and insomnia (p = 
.021) than controls. These symptoms (p == .014, p = .023, p = .044, respectively), in addition 
to nausea (p = .017), were more severe in the depressed group (Table VI). The sensation of 
well-being did not differ between depressed and control individuals (p > .05). 
 
Frequency of Symptoms (%) 
 Anxiety Depression 
 Yes 
 (N:38) 
No  
(N:80) 
P Yes  
(N:16) 
No  
(N: 102) 
P 
Pain 78.9 52.5 .006* 81.3 57.8 .074 
Fatigue 89.5 72.5 .038* 100 74.5 .021* 
Nausea 28.9 10.0 .009* 37.5 12.7 .023* 
Drowsy 71.1 69.6 .874 75 69.3 .774 
Dyspnea 63.2 57.5 .559 62.5 58.8 .781 
Anorexia 84.2 71.3 .127 100 71.6 .014* 
Insomnia 94.7 70.0 .002* 100 74.5 .021* 
Global Well Being  97.4 75.9 .004* 100 80.2 .070 
Table 5. Frequency of symptoms: comparative analysis in patients with and without 
depression or anxiety 
 
 Depression Anxiety 
 Yes No P Yes No P 
 (N:16) (N: 102)  (N:38) (N:80)  
Pain 4.00 ± 3.25 2.66 ± 3.03 .075 4.26 ± 3.38 2.16 ± 2.69 .001* 
Fatigue 5.63 ± 2.73 3.67 ± 2.99 .023* 5.18 ± 3.27 3.34 ±2.72 .003* 
Nausea 1.06 ± 1.88 .51 ± 1.71 .017* 1.13 ± 2.43 .33 ± 1.21 .009* 
Drowsiness 4.06 ± 3.36 3.35 ± 3.0 .427 3.87 ± 3.37 3.24 ± 2.88 .362 
Dyspnea 4.06 ± 3.44 2.92 ± 3.21 .261 3.95 ± 3.71 2.66 ± 2.94 .092 
Anorexia 6.50 ± 3.03 4.13 ± 3.66 .014* 5.58 ± 3.58 3.91 ± 3.60 .022* 
Insomnia 6.06 ± 2.43 4.17 ± 3.54 .044* 5.92 ± 3.11 3.71 ± 3.42 .001* 
(Mean± Standard Deviation of scores of the ESAS Depression and anxiety in accord with the HADS 
scale (≥ 11); Mann-Whitney Test) 
Table 6.  Presence of depression and anxiety, and intensity of physical symptoms. 
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4. Conclusion  
The high levels of anxiety (32.5%) and depression (32.5%) we found in this study are 
consistent with those reported in several previous international studies of patients with 
advanced chronic disease (Teunissen et al., 2007a; Lloyd-Williams et al., 2003; Wilson et al., 
2007; Durkin et al., 2003; Meyer et al., 2003; Noorani & Montagnini, 2007; Hotopf et al., 2002). 
From these results, we conclude that in patients with anxiety and depressive symptoms 
there is a strong association between the frequency and intensity of physical symptoms and 
the presence of psychological symptoms. Additionally our results suggests that the ESAS 
can be a useful screening tool to improve the clinical detection of anxious or depressive 
syndromes in terminal patients.  
We found that psychological disturbance was associated with significantly more frequent 
and intense physical symptoms. The explanation for this correlation might be that physical 
symptoms play an etiologic role in triggering psychological disturbance, or, conversely, that 
anxiety and depression tend to increase the perceived intensity of a symptom already 
experienced by the patient. Although our results do not allow us to decide between these 
alternative theories, they do indicate that, in the presence of intense and frequent physical 
symptoms, the probability of finding psychological disturbance is significantly higher. This 
finding underlines the importance of performing a comprehensive and multidisciplinary 
assessment of all terminally ill patients.  
Although multiple studies have sought the connection between depressed mood and 
physical symptoms, few have focused on the role of anxiety in this context. Chen and Chang 
(Chen & Chang, 2004) compared the physical symptom profiles of depressed and non-
depressed patients and found, as we did, that the former group presented with a 
significantly larger number of symptoms. They observed a higher prevalence of insomnia, 
pain, anorexia, and fatigue in patients who were classified by HADS as being depressed. 
Our results confirm these, although, in the case of pain, the differences between depressed 
and non-depressed patients were not statistically significant. A study by Lloyd-Williams et 
al. also showed a close association between physical symptoms and depression in palliative 
patients (Lloyd-Williams et al., 2004a). However, the results we and others have reported lie 
in contrast to a Dutch report (Teunissen, 2007a). In that study, whose design was very 
similar to ours, no association was found between depressed or anxious mood and the 
presence of physical symptoms. We believe the different results may be due to cultural 
differences between Chilean and Dutch patients, as well as to national differences in 
Karnofsky score (average 65 and 50 in the Chilean and Dutch population, respectively). It 
should also be noted that the previous study included fewer subjects than did the current 
one, potentially lending less validity to their data.  
The usefulness of the ESAS as a screening test in anxiety and depression is derived mainly 
from its sensitivity and negative predictive value. To comprehensively evaluate the 
usefulness of a screening test, sensitivity, specificity, and negative and positive predictive 
values must be evaluated. It is essential that both the sensitivity, which measures the ability 
of a particular tool to detect disease when it is present, and the negative predictive value, the 
probability that an individual with a negative test is healthy, be as higher as possible. 
Because a screening test is not intended to diagnose, it is less important that it has high 
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specificity, which measures the probability of detecting the absence of disease when there is 
none, because, after subjects with potential disease are identified, their assessment should 
always be confirmed and complemented by an adequate diagnostic procedure (in this case 
psychiatric interview based on DSM-IV).  
When we used a cutoff score of 2, the ESAS had high sensitivity and negative predictive 
value for both anxiety and depression, each exceeding 86%. When the cutoff score was 
raised to 5, the performance dropped considerably. Thus, in agreement with the results of a 
previous American study (Vignaroli et al., 2006) that also used the HADS as the gold 
standard, our data suggests that the ideal ESAS cutoff point to achieve an acceptable level of 
sensitivity and specificity when screening depression and anxiety in terminal patients is 2. 
Lloyd Williams et al. (2004b) found that the sensitivity and specificity of posing the simple 
question: are you depressed? to patients in palliative care was 74% and 55%, respectively. In 
addition to HADS, other tools have been designed to detect psychiatric syndromes, such as 
the Beck questionnaire, the Edinburgh Depression Scale, and the Schedule for Affective 
Disorders and Schizophrenia (SADS). However, because of their length, none of these 
instruments is practically applicable in clinical settings requiring daily simultaneous 
assessment and management of physical symptoms whose high frequency and intensity has 
been documented by this study and others (Chen & Chang, 2004; S Teunissen et al., 2007a; 
2007b; Oi-Ling et al., 2005). For this reason, we propose ESAS as a useful and sensitive tool 
that can help physicians to identify, and refer to psychiatric evaluation, those patients for 
whom advanced disease is accompanied by symptoms of depression or anxiety.  
In conclusion, in a sample of hospitalized patients with advanced chronic disease, we found 
that high levels of anxiety and depression were correlated with a higher frequency and 
intensity of physical symptoms. We found that for ESAS the ideal cutoff point to detect 
depressive mood and anxiety was a score of 2, which allowed ESAS to serve as a useful 
screening tool in this clinical context. 
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